Group Marinoni, Perren, Sadowski

Group Marinoni, Perren, Sadowski

Funding

SNF 310030_188639 (2020-2024) (Aurel Perren): "Metabolic changes in early and late progression steps of pancreatic neuroendocrine tumors"

ENETs CO-Synergy Award (2019-2022) (Ilaria Marinoni): "Studying poor responders to Temozolomide (TMZ) in Pancreatic Neuroendocrine Tumours (Pan-NETs). Unravelling mechanisms of primary resistance."

KLS-4227-08-2017 (Aurel Perren PI and Ilaria Marinoni Co-PI) (2018-2022)  "Precision medicine approach for novel epigenetic treatment for pancreatic neuroendocrine tumors (PanNET)"

Berner Krebsliga (Matthias Dettmer)   (2017 – 2022)  "Tumor heterogeneity and epigenetics in high-risk thyroid carcinomas"

Uniscentia (2020-2021) (Aurel Perren): "Epigenetic regulation in DAXX/ATRX negative Pancreatic Neuro-Endocrine Tumors (PanNETs)"

Wilhelm Sander Stiftung (Ilaria Marinoni)  (2020-2021)  "Identification of predictive biomarkers using primary 3D-culture of pancreatic Neuro-Endocrine Tumors and patient response data”